Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1-2 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1-2, 9.2012
- Creator
-
Munseri, P.
- Contributor
-
Kroidl, A.
Nilsson, C.
Moshiro, C.
Aboud, S.
Joachim, A.
Geldmacher, C.
Aris, E.
Buma, D.
Lyamuya, E.
Gotch, F.
Godoy-Ramirez, K.
Pallangyo, K.
Maboko, L.
Marovich, M.
Robb, M.
Hoelscher, M.
Janabi, M.
Mann, P.
Joseph, S.
Mfinanga, S.
Stoehr, W.
Mhalu, F.
Wahren, B.
Biberfeld, G.
McCormack, S.
Sandstrom, E.
Bakari, M.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P108
- URN
-
urn:nbn:de:1111-2016080725828
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Munseri, P.
- Kroidl, A.
- Nilsson, C.
- Moshiro, C.
- Aboud, S.
- Joachim, A.
- Geldmacher, C.
- Aris, E.
- Buma, D.
- Lyamuya, E.
- Gotch, F.
- Godoy-Ramirez, K.
- Pallangyo, K.
- Maboko, L.
- Marovich, M.
- Robb, M.
- Hoelscher, M.
- Janabi, M.
- Mann, P.
- Joseph, S.
- Mfinanga, S.
- Stoehr, W.
- Mhalu, F.
- Wahren, B.
- Biberfeld, G.
- McCormack, S.
- Sandstrom, E.
- Bakari, M.
- SpringerLink (Online service)
Other Objects (12)
HIV prevention by vaccine
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
P19-30. GTU® as beneficial HIV DNA vaccine vector system
Prospecting for an HIV vaccine
HIV vaccine research in Canada
Nanoparticles for HIV-1 vaccine delivery
HIV-1 vaccine immunogen design strategies
Is an HIV vaccine achievable? - Pros
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Polyfunctional Calcium Phosphate Nanoparticles as a Novel Vaccine Platform against HIV-1
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
HIV prevention by vaccine
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
P19-30. GTU® as beneficial HIV DNA vaccine vector system
Prospecting for an HIV vaccine
HIV vaccine research in Canada
Nanoparticles for HIV-1 vaccine delivery
HIV-1 vaccine immunogen design strategies
Is an HIV vaccine achievable? - Pros
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Polyfunctional Calcium Phosphate Nanoparticles as a Novel Vaccine Platform against HIV-1
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
HIV prevention by vaccine
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
P19-30. GTU® as beneficial HIV DNA vaccine vector system
Prospecting for an HIV vaccine
HIV vaccine research in Canada
Nanoparticles for HIV-1 vaccine delivery
HIV-1 vaccine immunogen design strategies
Is an HIV vaccine achievable? - Pros
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Polyfunctional Calcium Phosphate Nanoparticles as a Novel Vaccine Platform against HIV-1